Long COVID: Study Finds Distinct Immune Signature in Blood

Beyond the Fog: How the Long COVID Immune Signature is Revolutionizing Post-Viral Diagnostics For millions of people worldwide, the end of an acute respiratory infection was not the end of the battle, but the beginning of an invisible war within their own biology. While the world shifted its focus toward recovery and “returning to normal,” … Read more

Mpox Antibody Test Validated in Rwanda Outbreak 🔬

Rwanda has achieved a significant milestone in global health security with the successful development and validation of a locally-adapted antibody test for Mpox (formerly monkeypox). This isn’t simply about having a new diagnostic tool; it represents a crucial shift towards equitable access to scientific solutions and a more proactive approach to outbreak response in resource-limited … Read more

CAR-T Cells Reduce Alzheimer’s Plaques in Study

The search for effective Alzheimer’s treatments has long been plagued by incremental progress and limited clinical benefit. Now, a new study published in Proceedings of the National Academy of Sciences signals a potentially paradigm-shifting approach: repurposing CAR-T cell therapy – a technology that has revolutionized cancer treatment – to target the amyloid plaques at the … Read more

Flu Protection: New Nasal Spray Blocks All Strains

The fight against influenza just gained a potentially powerful new weapon: a nasal spray delivering targeted antibodies directly to the site of infection. While annual flu vaccines remain the cornerstone of prevention, their effectiveness is often hampered by viral mutations and the time required for production and distribution. This new approach, developed by researchers at … Read more

Butyrate & Vaccines: Gut Bacteria Boost Antibody Response

The future of mucosal vaccines – offering a non-invasive route to immunity against respiratory and intestinal infections – just received a significant boost. New research from POSTECH and ImmunoBiome in Korea reveals a critical link between gut bacteria, a key metabolite called butyrate, and the effectiveness of these next-generation vaccines. This isn’t simply about identifying … Read more

RSV Vaccines & Antibodies: Public Awareness is Rising

RSV Immunization: Beyond Baby Boomers – A New Era of Proactive Respiratory Defense A startling 60% of adults over 60 remain susceptible to severe RSV infection, a figure that underscores a critical gap in respiratory health protection. But the story isn’t just about older adults anymore. The recent surge in RSV cases, coupled with the … Read more

Gut Bacteria May Lower Allergy & Asthma Risk | DTU

The rising global prevalence of allergies and asthma in children – a trend linked to increasingly sterile environments and altered gut microbiomes – may soon face a powerful new countermeasure. Researchers at the Technical University of Denmark (DTU) have patented a breakthrough discovery: a specific metabolite produced by certain gut bacteria, specifically bifidobacteria, demonstrably reduces … Read more